Mirum Pharmaceuticals share price logo

Mirum Pharmaceuticals

NASDAQ: MIRM

Mid Cap

$87.13

+1.39

(+1.62%)

as on

Mirum Pharmaceuticals Stock Performance

as on November 4, 2026 at 7:59 am IST

  • Day's Low

    Day's High

    $86.54
    $88.54
    downward going graph

    0.68%

    Downside

    1.62%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $63.23
    $130.00
    downward going graph

    27.43%

    Downside

    49.20%

    Upside

    downward going graph

Mirum Pharmaceuticals share price movements today

Previous Close
$85.74
Open
$87.45
Volume
516.8K
Market Cap
$5.5B
Day's Low - High
$86.54 - $88.54
52 Week Low - High
$63.23 - $130.00

Mirum Pharmaceuticals Historical Returns

1 Month Return
+ 3.39 %
3 Month Return
-18.02 %
1 Year Return
+ 21.02 %
3 Year Return
+ 185.8 %
5 Year Return
+ 418.38 %

Mirum Pharmaceuticals Stock Fundamentals & Key Indicators

Check Mirum Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.5B

EPS (TTM)

-14.559

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-5.84

Industry PE ratio

-7.51

PEG Ratio

0.00

EBITDA

-776.8M

Revenue (TTM)

618.1M

Profit Margin

81.70%

Return On Equity TTM

-410.20%

Mirum Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Mirum Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$5.5B418.38%-5.8481.70%0.00%
Neutral$88.5B-36.16%-27.78-12.57%0.00%
StrongBuy$141.7B192.56%32.2786.04%0.00%
Buy$95.5B47.41%19.7685.77%0.40%

Stock Returns calculator for Mirum Pharmaceuticals Stock including INR - Dollar returns

The Mirum Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Mirum Pharmaceuticals investment value today

Current value as on today

₹1,31,317

Returns

₹31,317

(+31.32%)

Returns from Mirum Pharmaceuticals Stock

₹22,978 (+22.98%)

Dollar Impact

₹8,339 (+8.34%)

Analyst Recommendation on Mirum Pharmaceuticals Stock

Based on 8 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 8 analysts, 100% of analysts recommend a 'BUY' rating for Mirum Pharmaceuticals. Average target price of $153.43

Mirum Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on Mirum Pharmaceuticals.

What analysts predicted

43.21%UPSIDE

Target Price

$153.43

Current Price

$87.13

Analyzed by

8 Analysts

High

$200

Target

$153.43

Low

$137

Mirum Pharmaceuticals target price $153.43, a slight upside of 43.21% compared to current price of $87.13. According to 8 analysts rating.

Indian Investors' Interest in Mirum Pharmaceuticals Stock

Search interest for Mirum Pharmaceuticals Stock has increased by 9% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:9% versus previous 30 day period

Mirum Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
69
77
90
99
111
127
133
148
159
176
Gross Profit
51
57
69
76
88
104
107
120
131
145
Operating Income
-26
-24
-12
-24
-15
-4
2
-4
-63
-42
EBITDA
-15
-14
-4
-14
-4
4
9
4
-779
-11
Interest Expense
3
3
3
3
3
3
3
3
3
2
Depreciation
5
5
6
6
6
6
6
6
6
6
Income Before Tax
-24
-24
-13
-24
-13
-5
2
-4
-789
-65
Income Tax Expense
0
0
0
0
1
0
0
0
0
1
Net Income
-25
-24
-14
-23
-14
-5
2
-5
-790
-67
Net Profit Margin
74.24%
74.03%
76.98%
77.09%
79.37%
81.67%
80.80%
80.97%
81.94%
82.78%

Mirum Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
19
77
186
336
521
Gross Profit
-
0
0
17
64
139
255
420
Operating Income
-2
-54
-104
-173
-131
-109
-87
-22
EBITDA
-12
-52
-102
-65
-122
-136
-48
17
Interest Expense
-
-
0
17
15
15
14
14
Depreciation
4
0
0
0
3
10
23
24
Income Before Tax
-17
-52
-103
-83
-142
-162
-86
-21
Income Tax Expense
-
0
0
0
-6
0
1
1
Net Income
-17
-52
-103
-83
-135
-163
-87
-23
Net Profit Margin
0.00%
0.00%
0.00%
90.06%
83.94%
74.76%
75.77%
80.71%

Mirum Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-25
-24
-14
-23
-14
-5
2
-5
-790
-857
Operating Cash Flow
15
-3
3
-5
-1
12
39
6
-228
-273
Investing Cash Flow
0
-72
-18
0
-16
-6
-2
1
-11
-171
Financing Cash Flow
1
7
3
5
6
8
16
8
270
481
Change in Cash
16
-69
-10
0
-10
16
53
15
28
34

Mirum Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-17
-52
-103
-83
-135
-163
-87
-23
Operating Cash Flow
0
-39
-89
-132
-120
-70
10
55
Investing Cash Flow
-7
-127
37
48
7
-107
-90
-23
Financing Cash Flow
59
127
181
73
109
336
17
40
Change in Cash
51
-39
130
-10
-3
158
-63
75

Global Institutional Holdings in Mirum Pharmaceuticals

Check out the Institutions with significant holdings in Mirum Pharmaceuticals.

Funds
Holdings
Vanguard
7.48%
BlackRock, Inc.
6.76%
VANGUARD INDEX FUNDS
6.28%
Patrick Heron
6.21%
iShares
3.75%

Mirum Pharmaceuticals News & Key Events

  • img

    Today's Timeline - 12 October

    Mon, 05:35 PM

    -

    Mirum Pharmaceuticals announces positive topline results from Phase 3 EXPAND study for LIVMARLI in cholestatic liver diseases.

Insights on Mirum Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, MIRM stock has moved up by 185.8%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, MIRM has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 10 quarters, 69.22M → 176.24M (in $), with an average increase of 9.8% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -790.15M → -67.22M (in $), with an average increase of 1075.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 786.5% return, outperforming this stock by 765.5%

About Mirum Pharmaceuticals

Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing groundbreaking therapies for serious rare and orphan conditions. Its lead experimental drug, LIVMARLI, an oral treatment, is currently undergoing trials for progressive familial intrahepatic cholestasis (PFIC), Alagille syndrome, and biliary atresia. Furthermore, the company is advancing Volixibat to address intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Founded in 2018, Mirum Pharmaceuticals, Inc. operates from its headquarters in Foster City, California.
OrganisationMirum Pharmaceuticals
Headquarters989 East Hillsdale Boulevard, Foster City, CA, 94404, US
IndustryBiotechnology
CEOChristopher Peetz

Key Management of Mirum Pharmaceuticals

Name

Title

Mr. Eric H. Bjerkholt M.B.A., M.S.

Chief Financial Officer

Dr. Jean-Luc Girardet Ph.D.

Chief Technical Officer

Mr. Peter Radovich M.B.A., Ph.D.

COO & President

Mr. Andrew McKibben

Senior Vice President, Strategic Finance & Investor Relations

Mr. Douglas T. Sheehy J.D.

Chief Legal Officer & Secretary

Meredith Kiernan

Senior Director of Global Corporate Communications

Ms. Erin Campany

Chief People Officer

Ms. Lara Longpre MBA, MSC

Chief Development Officer

Ms. Vinita P. Kumar

Senior Vice President of Quality

Mr. Christopher Peetz

CEO & Director

FAQs

What is Mirum Pharmaceuticals share price today?

Mirum Pharmaceuticals share price today is $87.13 as on at the close of the market. Mirum Pharmaceuticals share today touched a day high of $88.54 and a low of $86.54.

What is the 52 week high and 52 week low for Mirum Pharmaceuticals share?

Mirum Pharmaceuticals share touched a 52 week high of $130.00 on and a 52 week low of $63.23 on . Mirum Pharmaceuticals stock price today i.e. is closed at $87.13,which is 32.98% down from its 52 week high and 37.79% up from its 52 week low.

What is Mirum Pharmaceuticals's market capitalisation today?

Mirum Pharmaceuticals market capitalisation is $0.01T as on .

How to invest in Mirum Pharmaceuticals Stock (MIRM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Mirum Pharmaceuticals on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Mirum Pharmaceuticals Stock (MIRM) from India?

Indian investors can start investing in Mirum Pharmaceuticals (MIRM) shares with as little as ₹94.73999786376953 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹947.40 in Mirum Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ). Based on Mirum Pharmaceuticals share’s latest price of $87.13 as on November 4, 2026 at 2:29 am IST, you will get 0.1148 shares of Mirum Pharmaceuticals. Learn more about fractional shares .

What are the returns that Mirum Pharmaceuticals has given to Indian investors in the last 5 years?

Mirum Pharmaceuticals stock has given 418.38% share price returns and 27.47% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?